Y

Researcher Profile

Y.Q. Shu

1

Publications

275

Citations

10

Co-Authors

1

Active Years

Publications

Open Access Journal Article Annals of Oncology Oct 01, 2017

First-line icotinib versus cisplatin/pemetrexed plus pemetrexed maintenance therapy for patients with advancedEGFR mutation-positive lung adenocarcinoma (CONVINCE): a phase 3, open-label, randomized study

Y.K. Shi · L. Wang · B.H. Han · W. Li +24 more

10.1093/annonc/mdx359 275 citations

Publication Timeline

2017

1

Frequent Co-Authors